119 related articles for article (PubMed ID: 37756453)
1. PROSPECTIVE SINGLE CENTER ANALYSIS OF OUTCOME STEM CELLS TRANSPLANTS IN PATIENTS WITH CEREBRAL PALSY.
Yousif NG; Yousif MG; Mohsen AAU; El-Bakaa HS; Younise MH; Altimimi AN; Nöth UA; Hassan AM
Pol Merkur Lekarski; 2023; 51(4):339-345. PubMed ID: 37756453
[TBL] [Abstract][Full Text] [Related]
2. Improvement in gross motor function and muscle tone in children with cerebral palsy related to neonatal icterus: an open-label, uncontrolled clinical trial.
Thanh LN; Trung KN; Duy CV; Van DN; Hoang PN; Phuong ANT; Ngo MD; Thi TN; Viet AB
BMC Pediatr; 2019 Aug; 19(1):290. PubMed ID: 31438885
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy.
Liu X; Fu X; Dai G; Wang X; Zhang Z; Cheng H; Zheng P; An Y
J Transl Med; 2017 Feb; 15(1):48. PubMed ID: 28235424
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety.
Zali A; Arab L; Ashrafi F; Mardpour S; Niknejhadi M; Hedayati-Asl AA; Halimi-Asl A; Ommi D; Hosseini SE; Baharvand H; Aghdami N
Cytotherapy; 2015 Feb; 17(2):232-41. PubMed ID: 25593079
[TBL] [Abstract][Full Text] [Related]
5. Whether the newly modified rhizotomy protocol is applicable to guide single-level approach SDR to treat spastic quadriplegia and diplegia in pediatric patients with cerebral palsy?
Zhan Q; Yu X; Jiang W; Shen M; Jiang S; Mei R; Wang J; Xiao B
Childs Nerv Syst; 2020 Sep; 36(9):1935-1943. PubMed ID: 31502037
[TBL] [Abstract][Full Text] [Related]
6. Administration of Autologous Bone Marrow-Derived Stem Cells for Treatment of Cerebral Palsy Patients: A Proof of Concept.
Bansal H; Singh L; Verma P; Agrawal A; Leon J; Sundell IB; Koka PS
J Stem Cells; 2016; 11(1):37-49. PubMed ID: 28296863
[TBL] [Abstract][Full Text] [Related]
7. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy.
Nguyen TL; Nguyen HP; Nguyen TK
Health Qual Life Outcomes; 2018 Aug; 16(1):164. PubMed ID: 30107811
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.
Nguyen LT; Nguyen AT; Vu CD; Ngo DV; Bui AV
BMC Pediatr; 2017 Apr; 17(1):104. PubMed ID: 28403842
[TBL] [Abstract][Full Text] [Related]
9. Selective dorsal rhizotomy for the treatment of severe spastic cerebral palsy: efficacy and therapeutic durability in GMFCS grade IV and V children.
D'Aquino D; Moussa AA; Ammar A; Ingale H; Vloeberghs M
Acta Neurochir (Wien); 2018 Apr; 160(4):811-821. PubMed ID: 29116382
[TBL] [Abstract][Full Text] [Related]
10. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.
Chen G; Wang Y; Xu Z; Fang F; Xu R; Wang Y; Hu X; Fan L; Liu H
J Transl Med; 2013 Jan; 11():21. PubMed ID: 23351389
[TBL] [Abstract][Full Text] [Related]
11. Effect of position on gross motor function and spasticity in spastic cerebral palsy children.
Rauf W; Sarmad S; Khan I; Jawad M
J Pak Med Assoc; 2021 Mar; 71(3):801-805. PubMed ID: 34057924
[TBL] [Abstract][Full Text] [Related]
12. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study.
Wang X; Cheng H; Hua R; Yang J; Dai G; Zhang Z; Wang R; Qin C; An Y
Cytotherapy; 2013 Dec; 15(12):1549-62. PubMed ID: 24100132
[TBL] [Abstract][Full Text] [Related]
13. Long-term functional benefits of selective dorsal rhizotomy for spastic cerebral palsy.
Dudley RW; Parolin M; Gagnon B; Saluja R; Yap R; Montpetit K; Ruck J; Poulin C; Cantin MA; Benaroch TE; Farmer JP
J Neurosurg Pediatr; 2013 Aug; 12(2):142-50. PubMed ID: 23713680
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
Hasnat MJ; Rice JE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
[TBL] [Abstract][Full Text] [Related]
15. The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years.
Beckung E; Carlsson G; Carlsdotter S; Uvebrant P
Dev Med Child Neurol; 2007 Oct; 49(10):751-6. PubMed ID: 17880644
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of instrumented gait analysis in interdisciplinary interventions on parents' perception of family-centered service and on gross motor function in children with cerebral palsy: a randomized controlled trial.
Fonvig CE; Rasmussen HM; Overgaard S; Holsgaard-Larsen A
BMC Pediatr; 2020 Sep; 20(1):411. PubMed ID: 32873289
[TBL] [Abstract][Full Text] [Related]
17. Effects of horse riding simulator on sitting motor function in children with spastic cerebral palsy.
Chinniah H; Natarajan M; Ramanathan R; Ambrose JWF
Physiother Res Int; 2020 Oct; 25(4):e1870. PubMed ID: 32808394
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of selective posterior rhizotomy for improving spasticity and gross movement in patients with cerebral palsy].
Xu J; Xu L; Zeng J; Yang XK; Li ZH; Shao GK; Li XY; Deng BW; Mu XH
Zhongguo Gu Shang; 2019 Sep; 32(9):815-819. PubMed ID: 31615177
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cerebral palsy with botulinum toxin: evaluation with gross motor function measure.
Yang TF; Chan RC; Chuang TY; Liu TJ; Chiu JW
J Formos Med Assoc; 1999 Dec; 98(12):832-6. PubMed ID: 10634023
[TBL] [Abstract][Full Text] [Related]
20. Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.
Unlu E; Cevikol A; Bal B; Gonen E; Celik O; Kose G
Clinics (Sao Paulo); 2010 Jun; 65(6):613-9. PubMed ID: 20613938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
